Catalyst Wire Dossier Catalyst Wire Dossier

EF5

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for EF5, covering 2013-01-16 to 2015-05-01. Get the full timeline:

Most recent: Clinical Trial Update: EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]

See pricing